Experience

Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 4,255,000 shares of common stock of NMI…

Davis Polk advised the underwriter in connection with the SEC-registered offering of 4,179,678 shares of common stock of OneMain Holdings, Inc. sold by Springleaf Financial Holdings, LLC on…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of senior notes by Ingersoll-Rand Global…

Davis Polk advised the representatives of the underwriters in connection with Gates Industrial Corporation plc’s initial public offering of 38,500,000 ordinary shares, at $19.00 per share,…

Davis Polk advised the global coordinators and bookrunners in connection with the initial public offering by PagSeguro Digital Ltd. and Universo Online S.A., as selling shareholder, of an…

Davis Polk advised the underwriter in connection with the $35.8 million SEC-registered secondary offering of 4,500,000 shares of common stock of Inspired Entertainment, Inc. by certain…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its approximately $5.4 billion acquisition of DST Systems, Inc. The transaction, which is expected to close by the third…

Davis Polk advised Compass Bank, a wholly owned subsidiary of BBVA Compass Bancshares, Inc., in connection with the offering of $750 million aggregate principal amount of its 2.875% senior…

Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500 shares of common stock of Loxo Oncology, Inc. The common stock is…